Takeda agrees $2.3bn sale of Japanese consumer health unitTakeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on Share XTakeda agrees $2.3bn sale of Japanese consumer health unithttps://pharmaphorum.com/news/takeda-agrees-2-3bn-sale-of-japanese-consumer-health-unit/
GSK has no immediate plans to spin off Pfizer joint ventureGlaxoSmithKline has made no plans to spin off or float its consumer healthcare joint venture with Pfizer, according Share XGSK has no immediate plans to spin off Pfizer joint venturehttps://pharmaphorum.com/news/gsk-spin-off-pfizer-joint-venture/
